Snapdeal CEO Booked For Selling Prescription Drugs Online


Maharashtra Food and Drug Administrator has ordered an FIR against e-commerce Major Snapdeal’s CEO Kunal Bahal and other bigwigs of the company for allegedly selling prescription drugs and other medicines online. FDA commissioner Harshdeep Kamble broke the news to the media persons.

Last month, FDA raided the Snapdeal’s premises in Mumbai after a tip-off that a number of drugs were being sold via the company’s portal. At that time, Snapdeal had assured authorities that it was delisting delisting the drugs from its portal and was assisting the regulator in the investigation.


The company was reportedly selling prescription drugs like Ascoril cough syrup, Vigora tablets, and other medicines online. The FIR has been ordered under the Drugs & Cosmetics Act, 1940 Sec. 18 (C), read with Rule 65. The rule stipulates that only a licensed retailer can sell drugs and that too on the basis of a doctor’s prescription.

DO NOT MISS:   How to Improve the Quality of Your Company's Products?

An official from FDA said that Snapdeal violated the FDA norms by selling those drugs online that require a doctor’s prescription. The authority had earlier issued a notice to the company and asked to furnish details about the drugs listed for the sale online.

-FDA orders FIR against Snapdeal CEO

Follow Us
Notify of

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Inline Feedbacks
View all comments
Would love your thoughts, please comment.x